PPT-Guidance: Adolescent Consent to HIV and STI Treatment and Prevention PowerPoint Presentation

wwwhivguidelinesorg MAY 2024 NYSDOH AIDS Institute Clinical Guidelines Program Purpose of This Guidance Inform New York State clinicians who provide primary care

Upload by romeo
Published on 2024-10-25

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/1060272" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Guidance: Adolescent Consent to HIV and ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Guidance: Adolescent Consent to HIV and STI Treatment and Prevention: Transcript

PPT-Guidance: Adolescent Consent to HIV and STI Treatment and Prevention PowerPoint Presentation

Presentation Embed Code

Download Presentation

Guidance: Adolescent Consent to HIV and STI Treatment and Prevention: Transcript

Related Contents

Minor Consent & Confidentiality

Harmonisation of the legal environment on Adolescent Sexual and Reproductive Health in

No one left behind: Increased

Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors

New Location for Adolescent Day Treatment Program

Adolescent-produced Child Sexual Material

Staff Sparks I: Adolescent Centered Environments

Adolescent HIV Care and Treatment

Legal History: Age of Majority, Age of Consent, and Parent-Initiated Treatment

Ethical and Legal Issues in the Treatment of Older Adults

Adolescent HIV Care and Treatment

The youth led Alliance is rolling out the Adolescent Health and Well-being Tool Kit with

Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment

Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs